Molecular mechanism of 1,25-dihydroxyvitamin D3inhibition of adipogenesis in 3T3-L1 cells

American Journal of Physiology - Endocrinology and Metabolism - Tập 290 Số 5 - Trang E916-E924 - 2006
Juan Kong1, Yan Chun Li
1Dept. of Medicine, Univ. of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.

Tóm tắt

We have investigated the molecular mechanism whereby 1,25-dihydroxyvitamin D3[1,25(OH)2D3] inhibits adipogenesis in vitro. 1,25(OH)2D3blocks 3T3-L1 cell differentiation into adipocytes in a dose-dependent manner; however, the inhibition is ineffective 24–48 h after the differentiation is initiated, suggesting that 1,25(OH)2D3inhibits only the early events of the adipogenic program. Treatment of 3T3-L1 cells with 1,25(OH)2D3does not block the mitotic clonal expansion or C/EBPβ induction; rather, 1,25(OH)2D3blocks the expression of C/EBPα, peroxisome proliferator-activated receptor-γ (PPARγ), sterol regulatory element-binding protein-1, and other downstream adipocyte markers. The inhibition by 1,25(OH)2D3is reversible, since removal of 1,25(OH)2D3from the medium restores the adipogenic process with only a temporal delay. Interestingly, although the vitamin D receptor (VDR) protein is barely detectable in 3T3-L1 preadipocytes, its levels are dramatically increased during the early phase of adipogenesis, peaking at 4–8 h and subsiding afterward throughout the rest of the differentiation program; 1,25(OH)2D3treatment appears to stabilize the VDR protein levels. Consistently, adenovirus-mediated overexpression of human (h) VDR in 3T3-L1 cells completely blocks the adipogenic program, confirming that VDR is inhibitory. Inhibition of adipocyte differentiation by 1,25(OH)2D3is ameliorated by troglitazone, a specific PPARγ antagonist; conversely, hVDR partially suppresses the transacting activity of PPARγ but not of C/EBPβ or C/EBPα. Moreover, 1,25(OH)2D3markedly suppresses C/EBPα and PPARγ mRNA levels in mouse epididymal fat tissue culture. Taken together, these data indicate that the blockade of 3T3-L1 cell differentiation by 1,25(OH)2D3occurs at the postclonal expansion stages and involves direct suppression of C/EBPα and PPARγ upregulation, antagonization of PPARγ activity, and stabilization of the inhibitory VDR protein.

Từ khóa


Tài liệu tham khảo

Arbour NC, Prahl JM, and DeLuca HF.Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.Mol Endocrinol7: 1307–1312, 1993.

10.1002/jcb.10507

10.1074/jbc.M210859200

10.1210/endo.134.5.8156925

10.1152/ajpendo.00151.2004

10.1016/S0378-1119(02)00726-6

10.1073/pnas.81.7.1991

10.1128/MCB.25.1.472-487.2005

10.1210/en.2003-0502

10.1038/35007504

10.1210/endo.143.6.8842

10.1016/0092-8674(75)90087-2

10.1016/0092-8674(76)90260-9

10.1016/0092-8674(74)90116-0

10.1152/ajprenal.0025.2001

10.1359/jbmr.1998.13.3.325

10.1073/pnas.95.5.2509

Hida Y, Kawada T, Kayahashi S, Ishihara T, and Fushiki T.Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3–L1 cells.Life Sci62: PL205–PL211, 1998.

10.1210/mend-5-8-1137

Jurutka PW, Hsieh JC, MacDonald PN, Terpening CM, Haussler CA, Haussler MR, and Whitfield GK.Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells.J Biol Chem268: 6791–6799, 1993.

Kawada T, Kamei Y, and Sugimoto E.The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators.Int J Obes Relat Metab Disord20,Suppl3: S52–S57, 1996.

10.1210/endo.139.5.5970

10.1038/227680a0

10.1210/me.2004-0324

10.1152/ajpendo.2001.281.3.E558

10.1172/JCI0215219

10.1073/pnas.94.18.9831

10.1210/jc.2004-1765

10.1016/S1471-4914(02)02294-3

10.1677/joe.0.1700425

10.1074/jbc.M207913200

10.1073/pnas.75.12.6054

10.1210/jc.2003-031398

10.1074/jbc.M207776200

Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D, and Kern PA.Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes.J Am Soc Nephrol10: 2158–2164, 1999.

10.1146/annurev.nutr.20.1.535

10.1101/gad.948702

10.1146/annurev.cellbio.16.1.145

10.1002/jcp.1041350326

10.1128/MCB.17.3.1552

Shi H, Norman AW, Okamura WH, Sen A, and Zemel MB.1a,25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes.FASEB J16: 1808–1810, 2002.

10.1096/fj.01-0584fje

10.1210/jc.2005-0216

Student AK, Hsu RY, and Lane MD.Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.J Biol Chem255: 4745–4750, 1980.

10.1210/mend.15.9.0693

10.1210/me.2002-0363

10.1073/pnas.0337434100

10.1073/pnas.0137044100

10.1210/endo.137.5.8612483

10.1006/bbrc.2001.4923

10.1128/MCB.16.8.4128

10.1038/ng0897-391

Zinser G, Packman K, and Welsh J.Vitamin D(3) receptor ablation alters mammary gland morphogenesis.Development129: 3067–3076, 2002.

Thông tin
Thông tin xuất bản

American Journal of Physiology - Endocrinology and Metabolism

Tập 290 Số 5

E916-E924

Thông tin tác giả